Improving orthopaedic/dental devices by surface chemical modification

到2010年，整形外科植入物的世界市场预计将达到1250亿美元。澳大利亚的大部分整形外科植入物都是进口的，预计到2010年其成本将超过3亿澳元。目前骨科患者的假体失败率高得令人无法接受。该项目旨在开发新的植入物，使其更好地融入骨骼，从而降低关节成形术的翻修率。这将导致我们老龄化人口的医疗保健成本显著降低，并提高假体接受者的生活质量。所获得的知识将促进骨科和种植牙科的优化，促进技术从学术界转移到相关的医疗器械行业。

The estimated world market for the orthopaedic implants is expected to be US$125 billion by 2010. Australia imports most of it's orthopaedic implants with an estimated cost in excess of AUD300 million by 2010. The current rate of prosthetic failures in orthopaedic patients is unacceptably high. The project aims to develop new implants that integrate better into bone, thus reducing the rate of revision arthroplasty. This would lead to a significant reduction in the cost of health care in our aging population and improve the quality of life for prosthetic recipients. Knowledge gained will facilitate the optimization of orthopaedic and implant dentistry, promoting the technology transfer from academia to the relevant medical device industry.